StemCyte Corp. Sheet
Related News: Cord Blood Stem Cells, Stem Cell Companies, Stem Cell InvestmentCorporate Summary (site quote):
StemCyte specializes in stem cell technology such as transplantation therapy, diagnostics, research and development, and genomics. One area of focus is in Umbilical Cord Blood Stem Cell Transplantation (UCBSCT), a substitute for traditional bone marrow transplantation (BMT). This new technology offers a new avenue of treatment for hundreds of thousands of patients with cancers and genetic diseases. Cord blood transplantation has proven to be effective with over 2,000 transplantations performed to date and shown to be equal to bone marrow transplantation in most aspects, including survival. However, due to the high cost, to date, more than ten years after the first cord blood transplantation, only a few tens of thousands specimens have been banked in the world, mostly by non-profit or government-backed agencies. Therefore, SCI intends to create the largest donor umbilical cord blood stem cell bank in the world.
StemCyte's vision is to establish the largest, most genetically diverse umbilical cord blood bank that can provide stem cells for all of humanity.
Mission Statement
StemCyte and its subsidiaries are dedicated to providing high quality, cost-effective, stem cell transplantation and therapy to all patients in need.
Management
The StemCyte team consists of medical, scientific, clinical laboratory, tissue typing, blood banking and stem cell professionals and experts, most of whom have been recruited from world-renowned medical institutions such as Harvard Medical School, UCLA, American Red Cross, City of Hope, and others.
Medical and Scientific Advisory Board
The esteemed advisors guide StemCyte in becoming the standard in the industry for cord blood banks.
* Karl Blume, M.D., Professor of Medicine & Former Director, Bone Marrow Transplant Program, Stanford University Medical Center* Richard Champlin, M.D., director, Bone Marrow Transplant Program, M.D. Anderson Cancer Center
* Stephen Forman, M.D., Chief & Director, Bone Marrow Transplant Program, City of Hope National Medical Center
* Steve Kleinman, M.D., Blood Bank Consultant & Former Director, Transfusion Medicine, UCLA Medical Center
* Joseph Rosenthal, M.D., Director, Pediatric Bone Marrow Transplantation, City of Hope National Medical Center
* Dick Stiehm, M.D., Professor of Medicine, UCLA Medical Center
Posted on May 28, 2005 02:01 PM